Article in Expert opinion on therapeutic targets, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 5 institutions in 2 countries.
Kazim SahinDepartment of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, Elazig, Turkey.
Cemal OrhanDepartment of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, Elazig, Turkey.
Ibrahim Hanifi OzercanDepartment of Pathology, Faculty of Medicine, Firat University, Elazig, Turkey.
Mehmet TuzcuDepartment of Molecular Biology, Faculty of Science, Firat University, Elazig, Turkey.
Birsen ElibolDepartment of Medical Biology, University of Bezmialem, School of Medicine, Istanbul, Turkey.ORCID 0000-0002-9462-0862
Taha Koray SahinDepartment of Internal Medicine, University of Hacettepe School of Medicine, Ankara, Turkey.
Ulkan KilicDepartment of Medical Biology, University of Health Sciences, School of Medicine, Istanbul, Turkey.
Sanjive QaziDivision of Hematology-Oncology, Department of Pediatrics, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine (USC KSOM), Los Angeles, CA, USA.
Fatih Mehmet UckunDivision of Hematology-Oncology, Department of Pediatrics, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine (USC KSOM), Los Angeles, CA, USA.
Fırat University · TRUniversity of Southern California · USBezmiâlem Vakıf Üniversitesi · TRHacettepe University · TRSağlık Bilimleri Üniversitesi · TR
Funding
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MYLES G COCKBURN · 1985 to 2026
$181.4M
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 NanoparticlesU01CA151837 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI UCKUN, FATIH M · 2010 to 2014
$2.3M
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALLR01CA154471 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI UCKUN, FATIH M · 2011 to 2015
$1.6M
Amplifying Radiation Potency Against Leukemic Stem CellsR21CA164098 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI UCKUN, FATIH M · 2012 to 2013
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Chemopreventive efficacy of stampidine in a murine breast cancer model. · full record | OpenQuestion